# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-114318
Filing Date
2020-04-22
Accepted
2020-04-22 07:57:37
Documents
8
Effectiveness Date
2020-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d888494ddefa14a.htm | DEFA14A | 41811
2 | GRAPHIC | g888494dsp005.jpg | GRAPHIC | 154606
3 | GRAPHIC | g888494dsp006.jpg | GRAPHIC | 211139
4 | GRAPHIC | g888494dsp007.jpg | GRAPHIC | 84409
5 | GRAPHIC | g888494dsp008.jpg | GRAPHIC | 87290
6 | GRAPHIC | g888494dsp009.jpg | GRAPHIC | 259129
7 | GRAPHIC | g888494dsp010.jpg | GRAPHIC | 207889
8 | GRAPHIC | g888494dsp11.jpg | GRAPHIC | 5376
| Complete submission text file | 0001193125-20-114318.txt |  | 1434287

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 20806673
SIC: 2834 Pharmaceutical Preparations